Patient
SITE011-0075
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE011 (ITA) (Dr. Jansen)
consented 2025-11-18
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 7
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-12-21 (study day 203); relationship: not assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-12-07 (study day 189); relationship: not assessed
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-24 (study day 115); relationship: NOT RELATED
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-08-26 (study day 86); relationship: NOT RELATED
Grade 3 Hypothyroidism — outcome: RECOVERED/RESOLVED; onset 2022-08-23 (study day 83); relationship: not assessed
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-07-17 (study day 46); relationship: NOT RELATED
Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-06-19 (study day 18); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.